Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finn Gustafsson

Showing results (71-80 of 547) with videos related to

Pageof 55
Sort By:
International Journal of Cardiology|July 6, 2016
Neurohormonal activation and exercise tolerance in patients supported with a continuous-flow left ventricular assist deviceMette Holme Jung, Jens Peter Goetze, Soeren Boesgaard, et al.
Fundamental & Clinical Pharmacology|November 3, 2011
Targeting the aldosterone pathway in cardiovascular diseaseFinn Gustafsson, Michel Azizi, Johann Bauersachs, et al.
Ugeskrift for Laeger|January 14, 2020
[Unexplained dyspnoea]Emil Wolsk, Kasper Rossing, Jørn Carlsen, et al.
Scandinavian Cardiovascular Journal : SCJ|February 7, 2015
Constrictive pericarditis in a contemporary Danish cohort: aetiology and outcomeNadia Lander Landex, Nikolaj Ihlemann, Peter Skov Olsen, et al.
European Journal of Clinical Investigation|May 11, 2011
Plasma sodium and mortality risk in patients with myocardial infarction and a low LVEFMorten Schou, Nana Valeur, Christian Torp-Pedersen, et al.
BMJ (Clinical Research Ed.)|November 15, 2003
Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective studyMorten Svensson, Finn Gustafsson, Søren Galatius, et al.
Ugeskrift for Laeger|September 24, 2004
[Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases]Morten Svensson, Finn Gustafsson, Søren Galatius, et al.
American Heart Journal|November 16, 2024
Chest pain and coronary artery disease in cardiac amyloidosis: Prevalence, mechanisms, and clinical implicationsNavid Noory, Oscar Westin, Mathew S Maurer, et al.
Open Heart|November 25, 2022
Uric acid in advanced heart failure: relation to central haemodynamics and outcomeTania Deis, Kasper Rossing, Mads Kristian Ersbøll, et al.
Drugs|February 3, 2022
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection FractionJulie K K Vishram-Nielsen, Daniela Tomasoni, Finn Gustafsson, et al.
Pageof 55

Showing results (71-80 of 547) with videos related to

Sort By:
Pageof 55
International Journal of Cardiology|July 6, 2016
Neurohormonal activation and exercise tolerance in patients supported with a continuous-flow left ventricular assist deviceMette Holme Jung, Jens Peter Goetze, Soeren Boesgaard, et al.
Fundamental & Clinical Pharmacology|November 3, 2011
Targeting the aldosterone pathway in cardiovascular diseaseFinn Gustafsson, Michel Azizi, Johann Bauersachs, et al.
Ugeskrift for Laeger|January 14, 2020
[Unexplained dyspnoea]Emil Wolsk, Kasper Rossing, Jørn Carlsen, et al.
Scandinavian Cardiovascular Journal : SCJ|February 7, 2015
Constrictive pericarditis in a contemporary Danish cohort: aetiology and outcomeNadia Lander Landex, Nikolaj Ihlemann, Peter Skov Olsen, et al.
European Journal of Clinical Investigation|May 11, 2011
Plasma sodium and mortality risk in patients with myocardial infarction and a low LVEFMorten Schou, Nana Valeur, Christian Torp-Pedersen, et al.
BMJ (Clinical Research Ed.)|November 15, 2003
Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective studyMorten Svensson, Finn Gustafsson, Søren Galatius, et al.
Ugeskrift for Laeger|September 24, 2004
[Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases]Morten Svensson, Finn Gustafsson, Søren Galatius, et al.
American Heart Journal|November 16, 2024
Chest pain and coronary artery disease in cardiac amyloidosis: Prevalence, mechanisms, and clinical implicationsNavid Noory, Oscar Westin, Mathew S Maurer, et al.
Open Heart|November 25, 2022
Uric acid in advanced heart failure: relation to central haemodynamics and outcomeTania Deis, Kasper Rossing, Mads Kristian Ersbøll, et al.
Drugs|February 3, 2022
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection FractionJulie K K Vishram-Nielsen, Daniela Tomasoni, Finn Gustafsson, et al.
Pageof 55